Financial Result for quarter and year ended 31st March, 2025

Net loss reportedNegative operating cash flowDebt to equity above the thresholdResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+9.2%Reaction day

₹2.82

prior close

₹3.04

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.2%+8.0% vs market

Civil Construction peers, median of 85sector+1.2%+8.0% vs sector

On the reaction day the stock moved 8.0 pts more than Nifty Microcap 250 and 8.0 pts more than its Civil Construction peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.7

10m

-0.3

15m

-1.0

30m

-1.6

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+9.2+1.2+8.0+1.2+8.0

Next day

+11.3+0.1+11.2-0.3+11.7

+6.4+0.9+5.5-0.1+6.5

+7.1+0.8+6.3-0.6+7.7

+6.7+1.4+5.3-0.3+7.1

+8.2+2.0+6.1+0.2+8.0

+6.7+2.3+4.5+1.0+5.8

15d

+7.4+5.2+2.3+2.2+5.3

+4.6+1.6+3.0-0.5+5.1

+1.8+7.7-5.9+1.7+0.1

-2.5+4.0-6.5-3.2+0.7

UpDownMarket · Nifty Microcap 250Sector · Civil Construction peers, median of 85Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board approved audited standalone and consolidated results for Q4 and FY ended March 31, 2025. Consolidated FY25 revenue jumped sharply to Rs 10,980.34 lakhs (vs Rs 3,723.86 lakhs in FY24), but the company swung to a consolidated net loss of Rs 132.22 lakhs from a Rs 92.50 lakh profit a year ago. Standalone revenue actually declined to Rs 2,285.31 lakhs with a net loss of Rs 119.58 lakhs. The revenue surge was largely driven by newly acquired subsidiary Trinity Ganesh Pvt Ltd (acquired Feb 7, 2025), which contributed Rs 8,682.13 lakhs. Operating cash flow remained negative at Rs (538.29) lakhs consolidated and trade receivables/payables ballooned sharply. Other board decisions include approval to acquire a 35% stake in Angolan pharma firm Angav Indústria Farmacêutica S.A., sale of ~6.25 Bigha land at Sanand (no impact on operations), appointment of new internal and secretarial auditors, and noted the resignation of Company Secretary Ms. Vinita Keswani.

Likely market impact

The headline revenue growth is acquisition-led rather than organic, and the swing to losses with persistent negative operating cash flow signals weak earnings quality – shareholders should track subsidiary margins, receivable collection, and the execution of the Angola foray. The land sale and auditor changes are routine, while the Angola investment adds long-term but uncertain optionality.